Survey of Raynaud's phenomenon and systemic sclerosis based on a representative sutdy of 10,000 South-Transdanubian Hungarian inhabitants

Clinical and Experimental Rheumatology

Volumn 23, Issue 6, 2005, Pages 801-808

  Czirják, László ^b   Kiss, C G ^b   Lovei C ^b   Suto G ^b   Varju C ^b   Fuzesi Z ^a   Illes T ^b   Nagy, Z ^b  

^a Fact Institute of Applied Social Science Research   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Epidemiology; Prevalence; Raynaud's phenomenon; Scleroderma; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; CENTROMERE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CAPILLAROSCOPY; CLINICAL EXAMINATION; CLINICAL FEATURE; DEMOGRAPHY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FEMALE; FREEZING; HEALTH SURVEY; HUMAN; HUNGARY; INTERVIEW; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RISK ASSESSMENT; RISK FACTOR; RURAL POPULATION; SELF REPORT; SKIN ULCER; SYSTEMIC SCLEROSIS; URBAN POPULATION;

ADOLESCENT; ADULT; AGED; DATA COLLECTION; FEMALE; HUMANS; HUNGARY; MALE; MIDDLE AGED; PREVALENCE; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC;

EID: 29944445184     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. OLSEN N, NIELSEN SL: Prevalence of primary Raynaud phenomena in young females. Scand J Clin Lab Invest 1978; 38: 761-4.
2. HESLOP J, COGGON D, ACHESON ED: The prevalence of intermittent digital ischaemia (Raynaud's phenomenon) in a general practice. J R Coll Gen Pract 1983; 33: 85-9.
3. MARICQ HR, WEINRICH MC, KEIL JE, LeROY EC: Prevalence of Raynaud's phenomenon in the general population. A preliminary study by questionnaire. J Chron Dis 1986; 39: 423-7.
4. LEPPERT J, ÅBERG H, RINGQVIST I, SÖRENSSON S: Raynaud's phenomenon in a female population: prevalence and association with other conditions. Angiology 1987; 38: 871-7.
5. SILMAN A, HOLLIGAN S, BRENNAN P, MADDISON P: Prevalence of symptoms of Raynaud's phenomenon in general practice. BMJ 1990; 301: 590-2.
6. WEINRICH MC, MARICQ HR, KEIL JE, McGREGOR AR, DIAT F: Prevalence of Raynaud phenomenon in the adult population of South Carolina. J Clin Epidemiol 1990; 43: 1343-9.
7. HARADA N, UEDA A, TAKEGATA S: Prevalence of Raynaud's phenomenon in Japanese males and females. J Clin Epidemiol 1991; 44: 649-55.
8. BARTELINK ML, WOLLERSHEIM H, van de LISDONK E, SPRUIJT R, van WEEL C: Prevalence of Raynaud's phenomenon. Neth J Med 1992; 41: 149-52.
9. RIERA G, VILARDELL M, VAQUÉ J, FONOLLOSA V, BERMEJO B: Prevalence of Raynaud's phenomenon in a healthy Spanish population. J Rheumatol 1993; 20: 66-9.
10. O'KEEFFE ST, TSAPATSARIS NP, BEETHAM WP Jr: Color chart assisted diagnosis of Raynaud's phenomenon in an unselected hospital employee population. J Rheumatol 1992; 19: 1415-7.
11. MARICQ HR, CARPENTIER PH, WEINRICH MC et al.: Geographic variation in the prevalence of Raynaud's phenomenon: Charleston, SC, USA vs Tarentaise, Savoie, France. J Rheumatol 1993; 20: 70-6.
12. MARICQ HR, CARPENTIER PH, WEINRICH MC et al.: Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison. J Rheumatol 1997; 24: 879-89.
13. VALTER I, MARICQ HR: Prevalence of Raynaud's phenomenon in Tartu and Tartumaa, Southern Estonia. Scand J Rheumatol 1997; 26: 117-24.
14. ASBOE-HANSEN G: Epidemiology of progressive systemic sclerosis in Denmark. In: BLACK CM and MYERS AR (Eds.): Systemic Sclerosis (Scleroderma). New York: Gower 1985; 78.
15. MICHET CJ, MCKENNA CH, ELVEBACK LR, KASLOW RA, KURLAND LT: Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985; 60: 105-13.
16. SILMAN A, JANNINI S, SYMMONS D, BACON P: An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 1988; 27: 286-90.
17. TAMAKI T, MORI S, TAKEHARA K: Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 1991; 283: 366-71.
18. GEIRSSON AJ, STEINSSON K, GUTHMUNDSSON S, SIGURTHSSON V: Systemic sclerosis in Iceland. A nationwide epidemiological study. Ann Rheum Dis 1994; 53: 502-5.
19. GALLO E, BIANCHI E, MOTTA A, PICCOLO N: Incidenza del fenomeno, di Raynaud in 1920 residenti in Milano. Minerva Cardioangiol 1994; 42: 65-71.
20. INABA R, MAEDA M, FUJITA S et al.: Prevalence of Raynaud's phenomenon and specific clinical signs related to progressive systemic sclerosis in the general population in Japan. Int J Dermatol 1993; 32: 652-5.
21. PALMER KT, GRIFFIN MJ, SYDDAL H, PANNETT B, COOPER C: Prevalence of Raynaud's phenomenon in great Britain and its relation to hand transmitted vibration: a national postal survey. Occup Environ Med 2000; 57: 48-452.
22. LeROY EC, MEDSGER TA Jr: Raynaud's phenomenon: a proposal for classification. Clin Exp Rheumatol 1992; 10: 485-8.
23. KAHALEH B, MEYER O, SCORZA R: Assesment of vascular involvement. Clin Exp Rheumatol 2003; 21(3 Suppl 29): S9-14.
24. NAGY Z, CZIRJÁK L: Predictors of survival in 171 patients with systemic sclerosis (scleroderma). Clin Rheumatol 1997; 16: 454-460.
25. FITZGERALD O, HESS EV, O'CONNOR GT, SPENCER GREEN G: Prospective study of the evolution of Raynaud's phenomenon. Am J Med 1988; 84: 718-26.
26. GERBRACHT DD, STEEN VD, ZIEGLER GL, MEDSGER TA Jr, RODNAN GP: Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum 1985; 28: 87-92.
27. HARPER FE, MARICQ HR, TURNER RE, LIDMAN RW, LeROY EC: A prospective study of Raynaud's phenomenon and early connective tissue disease. A five-year report. Am J Med 1982; 72: 883-8.
28. KALLENBERG CGM, WOUDA AA, HAUW T: Systemic involvement in immunologic findings in patients presenting with Raynaud's phenomenon. Am J Med 1980; 69: 675-80.
29. KALLENBERG CGM, WOUDA AA, HOET MH, Van VENROOIJ WJ: Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow-up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 1988; 47: 634-41.
30. WEINER ES, HILDEBLRANDT S, SENÉCAL JL et al.: Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. Arthritis Rheum 1991; 34: 68-77.
31. MARICQ HR, WEINRICH MC, KEIL JE et al.: Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989; 32: 998-1006.
32. MEDSGER TA, MASI AT: Epidemiology of systemic sclerosis. Ann Intern Med 1971; 74: 714-21.
33. KURLAND LT, HAUSER WA, FERGUSSON RH, HOLLEY KE: Epidemiologic features of diffuse connective tissue disorders in Rochester, Minnesota, 1951 through 1967 with special reference to systemic lupus erythematosus. Mayo Clin Proc 1969; 44: 649-63.
34. ROBERTS-THOMSON PJ, JONES M, HAKENDORF P et al.: A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy. Intern Med J 2001; 31: 220-9.
35. THOMPSON AE, POPE JE: Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis. J Rheumatol 2002; 29: 1867-73.
36. MAYES MD, LACEY JV Jr, BEEBE-DIMMER J et al.: Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003; 48: 2246-55.
37. SILMAN A: Scleroderma. In: SILMAN A, HOCHBERG MC eds. Epidemiology of the Rheumatic Diseases. Oxford University Press, 2001; 141-62.
38. ARNETT FC, CHO M, CHATTERJEE S, AGUILAR MB, REVEILLE JD, MAJES MD: Familial occurrence frequencies and relative risk for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum 2001; 44: 1352-62.
39. VALTER I, SARETOK S, MARICQ H: Prevalence of scleroderma spectrum disorders in the general population of Estonia. Scand J Rheumatol 1997; 26: 419-25.
40. Census 2001. 6. Settlement Population. Central Statistical Office. Budapest, 2002.
41. FÜZESI ZS, CZIRJÁK L, TISTYÁN L, ILLÉS T: General health status of the adult population in the South Transdanubian region of Hungary. Edited by T. Illés. Fact Institute, Pécs, Hungary, 2004; 12-76.
42. MARICQ HR: Wide-field capillary microscopy. Arthritis Rheum 1981; 24: 1159-65.
43. NAGY Z, CZIRJÁK L: Nailfold digital capillaroscopy in 447 with patients connective tissue diseases and Raynaud's phenomenon. J Eur Acad Dermatol Venereol 2004; 18: 62-68.
44. LeROY EC, MEDSGER TA, Jr: Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-6.
45. SPSS Manual. The SPSS Base 7,5 for Windows Users Guide. Chicago, IL, SPSS, 1997; SPSS for Windows 11.01; and SPSSP Answer Tree 2.1.1. Chicago, SPSS Inc., 1997.
46. MARICQ HR, WEINRICH MC: Diagnosis of Raynaud's phenomenon assisted by color charts. J Rheumatol 1988; 15: 454-9.
47. O'KEEFFE ST, TSAPATSARIS P, BEETHAM WP: Color chart assisted diagnosis of Raynaud's phenomenon in an unselected hospital employee population. J Rheumatol 1992; 19: 1415-7.
48. BRENNAN P, SILMAN A, BLACK C et al.: Validity and reliability of three methods used in the diagnosis of Raynaud's phenomenon. The UK Scleroderma Study Group. Br J Rheumatol 1993; 32: 357-61.
49. CZIRJÁK L, NAGY Z, SZEGEDI G: Survival analysis of 118 patients with systemic sclerosis. J Int Med 1993; 234: 335-7.